17 results on '"Mourissoux, Gaelle"'
Search Results
2. Should we reconsider Pneumocystis pneumonia presentation and treatment according to its underlying disease? An unsupervised cluster analysis of a retrospective multicentre study
3. Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])*
4. Should We Reconsider PneumocystisPneumonia Presentation and Treatment According to Its Underlying Disease?
5. Should We Reconsider Pneumocystis Pneumonia Presentation and Treatment According to Its Underlying Disease?: An Unsupervised Cluster Analysis of a Retrospective Multicenter Study
6. Impact of extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) rectal carriage in cancer patients admitted to the intensive care unit
7. Risk of superinfection in critically ill COVID-19 patients receiving tocilizumab plus dexamethasone
8. Main bronchial diameters in patients with very severe COPD
9. Feasibility of tocilizumab in ICU patients with COVID‐19
10. Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019
11. Characterisation of Acute Kidney Injury in Critically Ill Patients with Severe Coronavirus Disease-2019 (COVID-19)
12. Reduce Mortality and Morbidity in Acute Myeloid Leukemia With Hyperleukocytosis With Early Admission in Intensive Care Unit: A Retrospective Analysis
13. Contribution of the qPCR for the Diagnosis of Pneumocystosis
14. Is the Prognosis of Septic Shock Different in Case of Malignancies?
15. Characteristics and Prognosis Factors of Pneumocystis jiroveciiPneumonia According to Underlying Disease
16. Diagnosis of Pneumocystis jirovecii Pneumonia in an Intensive Care Unit: A 3-Year Prospective Study
17. Feasibility of tocilizumab in ICU patients with COVID‐19.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.